Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Overview

• 1.1 Product Overview and Scope of Chronic Obstructive Pulmonary Disease (COPD) Treatment
• 1.2 Classification of Chronic Obstructive Pulmonary Disease (COPD) Treatment by Types
  • 1.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Types in 2018
  • 1.2.3 Corticosteroids
  • 1.2.4 Phosphodiesterase Type 4 Inhibitors
  • 1.2.5 Bronchodilators
  • 1.2.6 Others
• 1.3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Application
  • 1.3.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Retail Pharmacies
  • 1.3.5 Other
• 1.4 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market by Regions
  • 1.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Chronic Obstructive Pulmonary Disease (COPD) Treatment Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Chronic Obstructive Pulmonary Disease (COPD) Treatment Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chronic Obstructive Pulmonary Disease (COPD) Treatment Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Chronic Obstructive Pulmonary Disease (COPD) Treatment Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chronic Obstructive Pulmonary Disease (COPD) Treatment Status and Prospect (2014-2024)
• 1.5 Global Market Size of Chronic Obstructive Pulmonary Disease (COPD) Treatment (2014-2024)

2 Company Profiles

• 2.1 AstraZeneca
  • 2.1.1 Business Overview
  • 2.1.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Orion Corporation
  • 2.2.1 Business Overview
  • 2.2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Novartis AG
  • 2.3.1 Business Overview
  • 2.3.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Novartis AG Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Boehringer Ingelheim International GmbH
  • 2.4.1 Business Overview
  • 2.4.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 CHIESI Farmaceutici
  • 2.5.1 Business Overview
  • 2.5.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 CHIESI Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 GlaxoSmithKline
  • 2.6.1 Business Overview
  • 2.6.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 GlaxoSmithKline Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Sunovion Pharmaceuticals
  • 2.7.1 Business Overview
  • 2.7.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Teva Pharmaceutical Industries
  • 2.8.1 Business Overview
  • 2.8.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 ​Mylan
  • 2.9.1 Business Overview
  • 2.9.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 ​Mylan Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue, Gross Margin and Market Share (2017-2018)

3 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Competition, by Players

• 3.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Chronic Obstructive Pulmonary Disease (COPD) Treatment Players Market Share
  • 3.2.2 Top 10 Chronic Obstructive Pulmonary Disease (COPD) Treatment Players Market Share
• 3.3 Market Competition Trend

4 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Regions

• 4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Market Share by Regions
• 4.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 4.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 4.5 South America Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)

5 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Countries

• 5.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Countries (2014-2019)
• 5.2 USA Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 5.3 Canada Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)

6 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Countries

• 6.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Countries (2014-2019)
• 6.2 Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 6.3 UK Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 6.4 France Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 6.5 Russia Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 6.6 Italy Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Countries

• 7.1 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Countries (2014-2019)
• 7.2 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 7.3 Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 7.4 Korea Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 7.5 India Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)

8 South America Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Countries

• 8.1 South America Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Countries (2014-2019)
• 8.2 Brazil Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Chronic Obstructive Pulmonary Disease (COPD) Treatment by Countries

• 9.1 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 9.3 UAE Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Growth Rate (2014-2019)

10 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Segment by Type

• 10.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue and Market Share by Type (2014-2019)
• 10.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Forecast by Type (2019-2024)
• 10.3 Corticosteroids Revenue Growth Rate (2014-2024)
• 10.4 Phosphodiesterase Type 4 Inhibitors Revenue Growth Rate (2014-2024)
• 10.5 Bronchodilators Revenue Growth Rate (2014-2024)
• 10.6 Others Revenue Growth Rate (2014-2024)

11 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Segment by Application

• 11.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Application (2014-2019)
• 11.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Forecast by Application (2019-2024)
• 11.3 Hospital Revenue Growth (2014-2019)
• 11.4 Clinic Revenue Growth (2014-2019)
• 11.5 Retail Pharmacies Revenue Growth (2014-2019)
• 11.6 Other Revenue Growth (2014-2019)

12 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Forecast (2019-2024)

• 12.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Forecast (2019-2024)
• 12.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Forecast by Regions (2019-2024)
• 12.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Forecast (2019-2024)
• 12.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Forecast (2019-2024)
• 12.6 South America Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology